Fujian Provincial Hospital
Fuzhou, Fujian, 350001, China
Location status: Recruiting
NCT Number: NCT06442943
Dementia is a chronic, progressive neurodegenerative disease characterized by acquired cognitive impairment as its core manifestation. The most common type of dementia is Alzheimer's Disease (AD), also known as "Senile Dementia," accounting for 60-80% of all dementia cases. Currently, there are approximately 10 million AD patients in China, with the number showing an increasing trend year by year, imposing a heavy economic and caregiving burden on families and society. Studies have shown that AD has a clinically silent period of 15 to 20 years (SCD\\MCI), where the risk of developing dementia is ten times higher than that of healthy elderly individuals. Nearly 50% of MCI patients progress to dementia within 5 years, and about 14.1% of SCD patients develop dementia within the same timeframe. Early detection, diagnosis, and intervention are currently the most effective strategies for preventing and treating AD. Therefore, this study aims to verify the intervention effect of integrated cognitive intervention in high-risk populations for senile dementia (SCD, MCI) based on the cognitive rehabilitation model through randomized controlled trials, and to analyze attrition rates, participation rates, etc., which have good research and application value.
Interested in participating?
Request Info55 year and older
All sexes
Interventional
Not applicable
Fuzhou, Fujian, 350001, China
Location status: Recruiting
Based on the cognitive rehabilitation model, this study aims to develop a digital multimodal cognitive intervention program, and conduct feasibility studies and randomized controlled trials. The intervention includes health knowledge education, exercise intervention, art intervention, and cognitive training, etc. The feasibility, effectiveness, and safety of this intervention approach will be evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline (pre-intervention), six-month follow-up (post-intervention)
The Chinese version of Montreal Cognitive Assessment will be used to assess the global cognitive function.The scale has a total score of 30 points, encompassing eight assessment sections: visual-spatial and executive function, naming, memory, attention, language, abstraction, delayed recall, and orientation. It involves multiple cognitive domains. A higher score indicates better cognitive functioning.
Time frame: Baseline (pre-intervention), six-month follow-up (post-intervention)
The Chinese version of Auditory Verbal Learning Test will be used to assess the memory. This includes immediate memory, short-term memory, long-term memory, and recognition memory. A higher score indicates better memory performance.
Time frame: Baseline (pre-intervention), six-month follow-up (post-intervention)
The Chinese version of Verbal Fluency Test will be used to assess the verbal fluency. A higher score indicates better verbal language performance.
Time frame: Baseline (pre-intervention), six-month follow-up (post-intervention)
The Chinese version of Boston Naming Test will be used to assess the naming difficulty. The total scores range from 0 to 30, a higher score indicates better language functioning.
Time frame: Baseline (pre-intervention), six-month follow-up (post-intervention)
The Chinese version of Shape Trail Test will be used to assess the execuite function. The shorter the usage time indicates better executive functioning.
Time frame: Baseline (pre-intervention), six-month follow-up (post-intervention)
The Chinese version of Rey-Osterrieth Complex Figure Test will be used to assess the visuospatial skills. A higher score indicates better visual-spatial structural abilities.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Chinese version of Health-Promoting Lifestyle Profile-II will be used to assess the health lifestyle . The total score range from 40 to 160. A higher score indicates better health lifestyle.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Chinese version of self-rated abilities for health practices scale will be used to assess the ability of health practice. The total score range from 0 to 112. A higher score indicates higher self-efficacy in healthy behaviors.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The University of California at Los Angels Loneliness scale will be used to assess the loneliness. A higher score indicates more lonliness.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Lubben Social Network Scale will be used to assess the social network. The lower score indicates lower risk of social isolation.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Quality of life-Alzheimer's disease scale will be used the quality of life. A higher score indicates better quality of life. The highest score is 39 points.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Self-rating Anxiety Scale will be used to assess the anxiety. The subjects will fill in the form based on their own situation in the past week.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Geriatric Depression Scale will be used to assess the depression. The Cronbach coefficient of this scale is 0.93.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Chinese version of Self-efficacy Scale will be used to assess the self-efficacy. The total score range from 10 to 40.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Self-esteem Scale will be used to assess the self-esteem. A higher score indicates higher level of Self-esteem.
Time frame: Baseline (pre-intervention), six-month follow-up (post-intervention)
The Athens Insomnia Scale will be used to assess the sleep quality.The Cronbach coefficient of this scale is 0.89, highest score is 24.
Time frame: Baseline (pre-intervention), three-month follow-up(during the intervention), six-month follow-up (post-intervention)
The Subjective Cognitive Decline Questionnaire 9 will be used to assess the subjective cognitive function. The Cronbach coefficient of this scale is 0.88, highest score is 9.
Contact information is provided by the study sponsor or research team.
Fujian Provincial Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07730957
Aberrant Motor Behavior in Dementia, Behavior
Amiens, France
View Trial DetailsNCT07719712
Cognition Disorders, Cognitive Dysfunction
Muğla, Turkey (Türkiye)
View Trial DetailsNCT07589595
Alzheimer Disease, Amyloid
Chandler, Arizona, United States
View Trial DetailsNCT07220512
Adnexal Diseases, Cognition Disorders
Winston-Salem, North Carolina, United States
View Trial Details